Immune dysregulation in cancer patients developing immune-related adverse events
2018 · British Journal of Cancer · 180 citations
https://doi.org/10.1038/s41416-018-0155-1
R
Rong Lü
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
160
Papers
1.7K
Citations
20
h-index
38
i10-index
Rong Lü is an academic researcher from National University of Singapore. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Chronic Lymphocytic Leukemia Research & Peptidase Inhibition and Analysis. The author has an h-index of 20, co-authored 136 publications.
ORCID: 0000-0003-4321-9144Papers by this author
worksDevelopment of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
2023 · JAMA Network Open · 44 citations
https://doi.org/10.1001/jamanetworkopen.2023.3646
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
2022 · Cancer Immunology Immunotherapy · 30 citations
https://doi.org/10.1007/s00262-022-03151-2
Analyzing allele specific RNA expression using mixture models
2015 · BMC Genomics · 18 citations
https://doi.org/10.1186/s12864-015-1749-0
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
2021 · Bone Marrow Transplantation · 17 citations
https://doi.org/10.1038/s41409-021-01475-8
Characterization of Carotenoid Cleavage Oxygenase Genes in Cerasus humilis and Functional Analysis of ChCCD1
2023 · Plants · 12 citations
https://doi.org/10.3390/plants12112114
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat